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Perfusion MR Imaging: 
Clinical Utility for the Differential
Diagnosis of Various Brain Tumors
Objective: To determine the utility of perfusion MR imaging in the differential
diagnosis of brain tumors.
Materials and Methods: Fifty-seven patients with pathologically proven brain
tumors (21 high-grade gliomas, 8 low-grade gliomas, 8 lymphomas, 6 heman-
gioblastomas, 7 metastases, and 7 various other tumors) were included in this
study. Relative cerebral blood volume (rCBV) and time-to-peak (TTP) ratios were
quantitatively analyzed and the rCBV grade of each tumor was also visually
assessed on an rCBV map.
Results: The highest rCBV ratios were seen in hemangioblastomas, followed
by high-grade gliomas, metastases, low-grade gliomas, and lymphomas. There
was no significant difference in TTP ratios between each tumor group (p>0.05).
At visual assessment, rCBV was high in 17 (81%) of 21 high-grade gliomas and
in 4 (50%) of 8 low-grade gliomas. Hemangioblastomas showed the highest
rCBV and lymphomas the lowest. 
Conclusion: Perfusion MR imaging may be helpful in the differentiation of the-
various solid tumors found in the brain, and in assessing the grade of the various
glial tumors occurring there.
espite the fact that conventional magnetic resonance (MR) imaging fol-
lowing the injection of gadolinium (Gd)-based contrast agents has led to
improved accuracy in the detection and characterization of various brain
tumors, the procedure suffers certain limitations related to the nonspecificity of con-
trast enhancement. Specifically, this does not provide a clear-cut differential diagnosis
between high- and low-grade tumors, between radiation necrosis and proliferating
neoplasms, or between postsurgical enhancement and a tumor that infiltrates the mar-
gins of the surgical bed. For these reasons, the clinical role of various functional imag-
ing techniques, including nuclear medicine methodologies such as 18F-fluorodeoxyglu-
cose positron emission tomography (FDG-PET), and functional MRI procedures such
as perfusion and diffusion-weighted imaging, and MR spectroscopy, has become an im-
portant area of investigation (1).
Among various functional imaging techniques, perfusion MR imaging using a rela-
tive cerebral blood volume (rCBV) map is particularly sensitive in depicting microvas-
culature, and tumor neovascularization can thus be detected (2 4). Several recent
studies (5 11) have reported that the potential uses of perfusion MR imaging in the
evaluation of brain tumors include tumor grading, the provision of guidance for stereo-
tactic biopsy, differentiation between radiation necrosis and recurrent glioma, and the
determination of prognosis and response to treatment. In those studies, the rCBV ra-
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Dtios of high-grade gliomas were significantly higher than
those of low-grade gliomas. Lee et al. (12) suggested that
the rCBV ratio cutoff value which permitted discrimination
between high- and low-grade gliomas was 2.60.
Although recent reports (5 7, 9, 12) of perfusion MR
studies of brain tumors have focused on the grading of
gliomas, the clinical utility of perfusion MR imaging for the
differential diagnosis of various brain tumors has not been
established. In this study, we investigated the rCBVs of
various brain tumors using perfusion MR imaging and eval-
uated the utility of this modality in the differential diagno-
sis of brain tumors.
MATERIALS AND METHODS
Patients
Fifty-seven patients with intracranial tumors confirmed
by pathologic examination were included in this study. The
group comprised 32 men and 25 women aged 13 to 81
(mean, 44.9) years. All underwent MR imaging prior to
treatment, which included surgery, chemotherapy, and ra-
diation therapy. The pathologic diagnosis of the 57 brain
tumors included 21 cases of high-grade glioma (12 glioblas-
toma multiformes, 3 anaplastic astrocytomas, 3 anaplastic
oligodendrogliomas, and 3 anaplastic oligoastrocytomas),
eight low-grade gliomas (3 oligodendrogliomas, 2 pilocytic
astrocytomas, 1 astrocytoma, 1 mixed oligoastrocytoma
and 1 pleomorphic xanthoastrocytoma), eight lymphomas,
six hemangioblastomas, seven metastases, and seven vari-
ous other tumors (2 germinomas, 2 medulloblastomas, 1
ganglioglioma, 1 choroid plexus papilloma, and 1 pineal
parenchymal tumor). The seven metastatic tumors arose
from squamous cell carcinoma of the lung in two patients,
and small cell carcinoma of the lung, large cell carcinoma
of the lung, and adenocarcinoma of the thyroid, cervix,
and rectum in one patient each. For pathologic confirma-
tion, 49 patients underwent total or subtotal tumor resec-
tion and all with lymphoma underwent biopsy for the veri-
fication of diagnosis. Since gliomas are typically heteroge-
neous and histologic samples obtained during biopsy may
be subject to sampling error (13, 14), we sought to avoid
this pitfall by including only gliomas which had undergone
subtotal or gross total resection.
Conventional and Perfusion MR Imaging
All patients underwent preoperative conventional and
perfusion MR imaging using a 1.5-T imager (Signa, GE
Medical Systems, Milwaukee, Wis., U.S.A.). For the latter,
we used a gradient-echo single-shot echo-planar imaging
(EPI) sequence with the following parameters: TR/ TE,
2000/ 60 msec; flip angle, 90 ; field of view, 28 28 cm;
128 128 matrix; section thickness/ gap, 5 mm/ 2 mm. A
series of images (10 slices, 50 images/slice) was obtained
at 2-second intervals before, during, and after administra-
tion of the contrast agent. After 10 seconds, during which
time the first five images were acquired and an imaging
baseline thus established, a bolus of 15 ml gadopentetate
dimeglumine (Magnevist, Schering, Berlin, Germany) was
power injected at a rate of 5 ml/second through an 18- or
20-gauge intravenous catheter. In each case, multisection
data acquisition was used to record a tumor in its entirety,
and a total of 500 images was obtained.
For the postprocessing of perfusion MR data, changes in
the relaxation rate ( R2) can be calculated from signal in-
tensity using the following equation:  R2=  ln (S/S0)/TE,
where ln is the natural logarithm, S is signal intensity, and
S0 is baseline signal intensity (15). Tracer recirculation was
reduced by fitting a gamma-variate function to the mea-
sured  R2 curve (15, 16). rCBV maps were generated as
gray scale images by numerical integration of the area un-
der a fitted curve on a pixel-by-pixel basis. Time-to-peak
(TTP) maps were also obtained as gray scale images from
the measured  R2 curve on a pixel-by-pixel basis (17, 18).
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Table 1. Relative Cerebral Blood Volume Ratios of 57 Brain Tumors
Tumor No. of Patients Range Mean SD
High-grade glioma 21 03.02 16.66 09.33 3.96
Low-grade glioma 08 01.30 05.07 03.64 1.50
Hemangioblastoma 06 18.34 40.75 26.60 8.98
Lymphoma 08 01.38 02.07 01.80 0.23
Metastasis 07 03.16 13.27 08.34 3.02
Germinoma 02 04.79 and 4.85 04.82
Ganglioglioma 01 05.50
Choroid plexus papilloma 01 11.39
Pineal parenchymal tumor 01 02.97
Medulloblastoma 02 16.08 and 12.45 14.27Qualitative and Quantitative Analysis
For quantitative analysis, normal white matter within the
contralateral hemisphere was used as the internal reference
standard (19). To determine maximum rCBV ratios, a re-
gion of interest (ROI), including at least 20 pixels, was
carefully established in the area of a tumor which accord-
ing to an rCBV map showed maximal intensity, and also in
contralateral normal white matter. A circular ROI was
drawn, and measured three times, and its average value
was then recorded. The same ROI was also applied to TTP
maps. rCBV or TTP ratios were calculated by dividing the
mean CBV or TTP of a tumor by that of contralateral nor-
mal white matter.
Visual inspection of rCBV map images showed that the
signal intensity of all tumors was higher than or similar to
that of normal white matter. Thus, after visual grading, we
assigned a tumor to the high rCBV group if rCBV maps de-
picted any intratumoral area with a signal intensity higher
than that of gray matter. Similarly, if visual grading
showed that the signal intensity of all intratumoral areas
was similar to or lower that of gray matter, the tumor was
assigned to the low rCBV group. In addition, we assessed
the relationship between the visual grades depicted by
rCBV maps and the intratumoral enhancement seen at
contrast-enhanced T1-weighted imaging.
Statistics
Student’s t test was used to determine statistical differ-
ences in rCBV or TTP ratios regarding the histopathologic
grades of gliomas and to analyze quantitative differences
in rCBV ratios between the two groups visually catego-
rized as high or low CBV on rCBV maps. The one-way
ANOVA test was used to decide whether rCBV or TTP ra-
tios varied between tumor groups. A p value of less than
0.05 was considered statistically significant.
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Table 2. Relative Time-to-peak (TTP) Ratios of 57 Brain Tumors
Tumor No. of Patients Range Mean SD
High-grade glioma 21 0.61 1.38 0.98 0.15
Low-grade glioma 080 . 7 1 1.64 1.02 0.29
Hemangioblastoma 061 . 0 3 1.21 1.11 0.07
Lymphoma 080 . 9 8 1.22 1.07 0.07
Metastasis 071 . 0 3 1.34 1.17 0.12
Germinoma 02 0.88 and 1.28 1.08
Ganglioglioma 011 . 1 8
Choroid plexus papilloma 011 . 2 1
Pineal parenchymal tumor 011 . 1 2
Medulloblastoma 02 1.09 and 1.12 1.11
Fig. 1. Malignant mixed oligoastrocytoma in a 30-year-old man. Conventional T2-weighted MR image (A) shows a large infiltrative mass
with high signal intensity in both frontal lobes and the genu of the corpus callosum. Enhanced T1-weighted MR image (B) reveals no
contrast enhancement. rCBV map (C) depicts foci of increased rCBV within the tumor (arrow). The measured rCBV ratio was 16.27.
ABCRESULTS
rCBV and TTP ratios are summarized in Tables 1 and 2.
For high- and low-grade gliomas, these varied from 3.02 to
16.66 (mean SD, 9.33 3.96) and from 1.30 to 5.07
(mean SD, 3.64 1.50), respectively (Figs. 1, 2). The dif-
ference was statistically significant (p=0.001, Student’s t
test). In general, the rCBV ratios of high-grade gliomas of a
specific histologic type were not significantly different from
those of other high-grade gliomas, and this was also the
case with low-grade gliomas. Hemangioblastomas showed
the highest rCBV ratios (mean, 26.60 8.98), which was
statistically higher than those of all other tumors (p
<0.001). The rCBV ratios of metastases varied from 3.16
to 13.27 (mean, 8.34 3.02), a finding similar to that for
high-grade gliomas. Lymphomas had low rCBV ratios (Fig.
3), ranging from 1.38 to 2.07, values which were signifi-
cantly lower than those of high-grade gliomas (p =0.001)
or metastases (p =0.032) (Fig. 4).
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Fig. 2. Low-grade astrocytoma in a 39-year-old woman. Conventional T2-weighted MR image (A) reveals the presence of a large infiltra-
tive mass with very high signal intensity in the right frontal lobe. Enhanced T1-weighted MR image (B) shows no contrast enhancement.
rCBV map (C) demonstrates homogeneous low rCBV, the ratio of which was 1.82.
ABC
Fig. 3. Diffuse large B-cell lymphoma in a 68-year-old woman. Conventional T2-weighted MR image (A) depicts a round mass with inter-
mediate signal intensity in the left thalamus. Enhanced T1-weighted MR image (B) demonstrates homogeneous intense enhancement,
while rCBV map (C) shows homogeneous low rCBV (ratio, 1.72).
ABCThe TTP ratios of all tumor groups were similar to those
of white matter, and there were no statistically significant
differences in TTP ratios between tumor groups (p > 0.05).
The relationship between visual grade according to rCBV
maps and the intratumoral enhancement seen at contrast-
enhanced T1-weighted imaging is summarized in Table 3.
At visual assessment of tumors on rCBV maps, a high
rCBV was found in 17 (81%) of 21 high-grade gliomas. In
five of these 17 patients, however, contrast-enhanced T1-
weighted images demonstrated no obvious enhancement
within the tumor. Visual examination of rCBV maps
showed that four (19%) of 21 high-grade gliomas belonged
to the low rCBV group, and in two of these, contrast en-
hanced T1-weighted images depicted intratumoral en-
hancement. After visual inspection, four of the eight low-
grade gliomas, namely two oligodendrogliomas, one astro-
cytoma, and one oligoastrocytoma, were assigned to the
low rCBV group, and at contrast-enhanced T1-weighte
imaging, enhancement of theses tumors was either absent
or equivocal. High rCBV was visually determined in two
pilocytic astrocytomas, one oligodendroglioma, and one
pleomorphic xanthoastrocytoma.
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Fig. 4. Metastatic squamous cell carcinoma of the lung in a 56-year-old man. Conventional T2-weighted MR image (A) demonstrates a
lobulated mass with intermediate signal intensity in the right cerebellum. Enhanced T1-weighted MR image (B) shows relatively strong
enhancement. rCBV map (C) depicts the tumor’s relatively high rCBV, the ratio of which was 7.88.
ABC
Table 3. The Relationship Between Visual Grades Depicted by Relative Cerebral Blood Volume Maps and Intratumoral
Enhancement Seen at Enhanced T1-Weighted Imaging of 57 Brain Tumors
Number of patients
Tumor High rCBV on rCBV map Low rCBV on rCBV map
(Number of Patients) Positive Enhancement  Negative Enhancement  Positive Enhancement  Negative Enhancement
at CE MR at CE MR at CE MR at CE MR
High-grade glioma (21) 12 5 2 2
Low-grade glioma (8) 03 104
Lymphoma (8) 000 8 0
Hemangioblastoma (6) 060 0 0
Metastasis (7) 060 1 0
Germinoma (2) 020 0 0
Ganglioglioma (1) 010 0 0
Choroid plexus papilloma (1) 010 0 0
Pineal parenchymal tumor (1) 000 1 0
Medulloblastoma (2) 020 0 0
Note. two pilocytic astrocytomas and one pleomorphic xanthoastrocytoma,     one oligodendroglioma rCBV mapping demonstrated high rCBV in all heman-
gioblastomas, which at contrast-enhanced T1-weighted
imaging showed strong contrast enhancement (Fig. 5). In
all lymphomas, on the other hand, low rCBV and strong
homogeneous enhancement were apparent. High rCBVs
were found in six of seven metastases, each of the two ger-
minomas, each of the two medulloblastomas, the gangli-
oglioma, and the choroid plexus papilloma. The pineal
parenchymal tumor showed low rCBV and contrast en-
hancement.
The rCBV ratios of tumors assigned at visual examina-
tion to the low and the high group ranged from 1.30 to
4.06 (mean, 2.48), and from 4.62 to 40.75 (mean, 12.07),
respectively. This difference was statistically significant (p
= 0.000).
DISCUSSION
The presence of contrast enhancement at conventional
MR imaging represents a pathologic alteration in the
blood-brain barrier, with or without concomitant vascular
hyperplasia, whereas the degree of MR perfusion abnor-
mality reflects the degree of microvascularity, with or
without destruction of the blood-brain barrier (5, 6, 20,
21).
In the grading of gliomas, previous studies (5 7, 9) re-
ported statistically significant differences in rCBV values
between low- and high-grade tumors, and demonstrated
that high-grade gliomas with high rCBV might not enhance
at contrast-enhanced MR imaging. Similar results were ob-
tained in our study. There was a statistically significant dif-
ference in rCBV ratios between low- and high-grade
gliomas (p =0.001), and five high-grade gliomas with high
rCBV showed no obvious contrast enhancement. In our
study, four high-grade gliomas had low rCBV, a finding
which reflects a low level of neovascularity or contrast
leakage through the altered blood-brain barrier. Sugahara
et al. (22) reported two cases of anaplastic glioma without
increased vascularity, suggesting that a lack of neovascular-
ity within a tumor did not necessarily indicate benignancy.
Our results also showed that in two of the four high-grade
gliomas with visually determined low rCBV, enhancement
was evident at contrast-enhanced T1-weighted MR imag-
ing, a finding which may reflect a falsely low rCBV related
to contrast leakage through the altered blood-brain barrier.
When this is disrupted, perfusion MR may underestimate
the real microvascular blood volume. In a region of severe
blood-brain barrier breakdown, unwanted T1 effects
caused by extravasated gadolinium counteract the T2 sig-
nal-lowering effects of gadolinium, resulting in falsely low
rCBV values (23).
Despite their relatively low rCBV ratios, a signal intensi-
ty equal to or lower than that of gray matter was apparent
at visual analysis of rCBV maps in only four of eight low-
grade gliomas; in the other four, rCBV was high. These re-
sults may be explained by the relatively high neovasculari-
ty of the tumors, revealed at histologic examination.
Likewise, previous studies (9, 23) described pilocytic astro-
cytomas containing foci of high rCBV, and oligoden-
drogliomas, regardless of their histologic grade, with high
blood volume foci. Despite the fact that an oligoden-
droglioma, independently of its histologic grade, is relative-
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Fig. 5. Solid hemangioblastoma in a 62-year-old woman. Conventional T2-weighted MR image (A) shows that in the left cerebellum, a
lobulated mass with inhomogeneously high signal intensity is present. Enhanced T1-weighted MR image (B) shows strong enhance-
ment. rCBV map (C) demonstrates very high rCBV (ratio, 40.75).
ABCly hypervascular, our study demonstrated a statistically sig-
nificant difference in rCBV ratio between low-grade and
anaplastic oligodendroglioma (p =0.009, Student’s t test).
To clarify this discrepancy, further study of a larger series
is, however, necessary.
In our study, a frequently occurring hypervascular tumor
such as hemangioblastoma was shown to have an exceed-
ingly high rCBV ratio; this ratio was lowest in lymphomas,
in which it was significantly lower than in high-grade
gliomas or metastases. Sugahara et al. (24) reported that
cerebral lymphomas tended to have lower vascularity than
malignant gliomas.
Our study findings suggest that rCBV maps based on per-
fusion MR imaging data can provide additional information
for use in the differential diagnosis of brain tumors. First,
they may be useful in differentiating solid cerebellar tu-
mors, including metastatic tumor, lymphoma, and solid he-
mangioblastoma, in adults; these occasionally show similar
conventional MR features of homogeneous enhancement
at contrast-enhanced T1-weighted imaging, and intermedi-
ate or mild hyperintensity at T2-weighted imaging, though
in our cases, quantitative analysis showed indicated that
the signal intensity of lymphoma was similar to or lower
than that of gray matter, while hemangioblastomas and
metastases showed high intensity on rCBV maps of perfu-
sion MR imaging.
Second, an rCBV map is also useful in differentiating cys-
tic astrocytoma from cystic hemangioblastoma. At conven-
tional MR imaging, both cerebellar hemangioblastomas
and astrocytomas often appear as small, enhancing nodules
Utility of Perfusion MR in Differentiation of Brain Tumors
Korean J Radiol 3(3), September 2002 177
Fig. 6. Cystic hemangioblastoma in a
16-year-old boy. Enhanced T1-weighted
MR image (A) depicts a cystic mass
with a strongly enhancing mural nodule
(arrow) in the cerebellum. rCBV map (B)
reveals very high rCBV (arrow), the
measured ratio of which was 34.77.
AB
Fig. 7. Pilocytic astrocytoma in a 13-
year-old girl. Enhanced T1-weighted MR
image (A) shows that the cerebellum
contains a cystic mass with strongly en-
hancing mural nodules, similar to the he-
mangioblastoma shown in Fig. 6. rCBV
map (B) indicates that the rCBV ratio of
these nodules in high (4.65) (arrows),
but lower than that of the hemangioblas-
toma.
ABwithin a well circumscribed, thin-walled cyst, as in our cas-
es. Despite some differential features such as an intratu-
moral signal void, differentiation by conventional MR
imaging alone is difficult, especially where tumors are
smaller than 1cm (25, 26). Perfusion MR imaging, howev-
er, permits differentiation without the need for additional
invasive conventional angiography. Quantitative analysis
indicated that the rCBV ratio of hemangioblastomas was
significantly higher than that of cerebellar astrocytomas,
and it was also found that compared with that of gray mat-
ter, the signal intensity of hemangioblastomas was higher,
while that of cystic astrocytomas was slightly higher (Figs.
6, 7).
Compared to other studies (5 7), the rCBV ratios of tu-
mors in our series were higher in the titer, a fact which
may be due to the different way in which ROIs were se-
lected: the ROIs we chose were, for each tumor, in the area
which showed maximal perfusion.
Our study findings revealed no differences in TTP be-
tween various tumor groups. We noticed that TTP was a
useful parameter in stroke cases (27), so sought to identify
on TTP maps any differences between various tumor
groups, especially between lymphomas and other hyper-
vascular tumors. TTP maps, in contrast to rCBV maps,
played only a small part in both the grading and differenti-
ation of the various brain tumors we encountered.
A limitation of this study is the inclusion of only small
numbers of cases of low-grade glioma, especially low-grade
astrocytoma and oligodendroglioma. To determine the
practical utility of perfusion MR imaging in differentiating
between low- and high-grade astrocytomas or oligoden-
drogliomas, further study involving a larger series of these
tumors is needed. For the grading of gliomas, determina-
tion of a cut-off value for rCBV may be helpful.
In summary, the rCBV ratios of high-grade gliomas were
significantly higher than those of low-grade gliomas. For
hemangioblastomas, these ratios were exceedingly high;
for high-grade gliomas and metastases they were relatively
high; and for low-grade gliomas and lymphomas they were
relatively low. Visual grading based on rCBV mapping
provided added information about tumor characteristics.
Perfusion MR imaging may be helpful in the differentiation
of the various solid tumors found in the brain, as well as in
assessing the grade of the various glial tumors occurring
there.
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